Evidence map›Paper›PMID 29177720›Full record

ArticleBioprocess and biosystems engineering2018

Recombinant biosynthesis of bacterial cellulose in genetically modified Escherichia coli.

Gizem Buldum, Alexander Bismarck, Athanasios Mantalaris

Open access · hybridAbstract read
In one paragraph

Article in Bioprocess and biosystems engineering, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 76 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Research progress of the biosynthetic strains and pathways of bacterial cellulose.Journal of industrial microbiology & biotechnology · 2022
    Review
  11. Review
  12. Review
  13. Review
  14. Enhanced Production of Bacterial Cellulose inJournal of microbiology and biotechnology · 2020
    Article
  15. Industrial-Scale Production and Applications of Bacterial Cellulose.Frontiers in bioengineering and biotechnology · 2020
    Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 3 countries.

Gizem BuldumBiological Systems Engineering Laboratory (BSEL), Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Alexander BismarckPolymer and Composite Engineering (PaCE) Group, Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Athanasios MantalarisBiological Systems Engineering Laboratory (BSEL), Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK. a.mantalaris@imperial.ac.uk.
Imperial College London · GBUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial cellulose (BC) exhibits unique properties such as high purity compared to plant-based cellulose; however, commercial production of BC has remained a challenge, primarily due to the strain properties of cellulose-producing bacteria. Herein, we developed a functional and stable BC production system in genetically modified (GM) Escherichia coli by recombinant expression of both the BC synthase operon (bcsABCD) and the upstream operon (cmcax, ccp Ax). BC production was achieved in GM HMS174 (DE3) and in GM C41 (DE3) by optimization of the culture temperature (22 °C, 30 °C, and 37 °C) and IPTG concentration. BC biosynthesis was detected much earlier in GM C41 (DE3) cultures (3 h after IPTG induction) than those of Gluconacetobacter hansenii. GM HMS174 (DE3) produced dense fibres having a length of approximately 1000-3000 μm and a diameter of 10-20 μm, which were remarkably larger than the fibres of BC typically produced by G. hansenii.

Indexed as

Escherichia coliMicroorganisms, Genetically-ModifiedOperonCelluloseGluconacetobacterCelluloseBacterial celluloseEscherichia coliOptimization of culture conditionsPlasmid maintenanceRecombinant biosynthesis

Identifiers

PMID29177720
PMCPMC5773641
OpenAlexW2769039398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.